TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says. May 27, 2005
TCL Archive Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility February 1, 1980
